Eric Meier Email & Phone Number

Eric Meier has over 25 years of experience in the health care market place specifically in the development and commercialization of disruptive and innovative health care solutions. These solutions span software, medical devices, drug delivery, and drug compounds. He has built world class teams with deep domain knowledge in the areas of behavioral health, neuroscience, oncology, cardiovascular, and general surgery. He has extensive experience in fund raising from a variety of US, European, and Asian sources including institutional, family office, strategic, and non-profit entities. He has raised over $200 million to date and structured a variety of complex transactions.Mr. Meier has had extensive operating experience in both large and emerging companies. In 2024, Mr. Meier joined Neuroflow following the acquisition of Owl as President of Behavioral Health Markets responsible for Neuroflow's commercial presence in the Behavioral Health Market.In 2017, Mr. Meier joined Owl, a digital health company providing measurement based care and analytics to providers and health plans for the Behavioral Health market, as President and CEO. The platform is in use with leading providers in 35 states and has delivered over 2M assessments to patient suffering from mental health and substance use disorders. In 2024, the company was acquired by Neuroflow.In 2010, Mr. Meier joined Cervel Neurotech, a medical device company providing targeted non-invasive deep brain stimulation for psychiatric and neurologic disorders, as President and CEO. Since 2010, Cervel completed a variety of successful clinical studies for patients suffering from depression. The company built a world class management team and raised in excess of $25M. In 2017, The Company was acquired by Rio Grande Neurosciences.In 2000, Mr. Meier founded Calypso Medical and served as its President and CEO from 2000 - 2010, a medical device company providing real time tumor tracking company for the delivery of external beam radiation therapy. During that period, the company raised in excess of $175M, achieved five FDA clearances and treated in excess of 50,000 patients. In 2011, the company was acquired by Varian Medical Systems. At Johnson and Johnson, he led a variety of corporate development activities focused upon identifying new markets, and technologies at several operating companies.Mr. Meier is a board member of Clarksdale Collegiate, a K-12 charter school located in Clarksdale, MS and Horizons, a STEM summer school program, located in Savannah, GA . He is also an active angel investor.

Listed skills include Medical Devices, Start Ups, Market Development, Fda, and 31 others.